DMEMEDS shared post via Reuters: Isis Pharma's blood thinner succeeds in mid-stage trial

(Reuters) - Isis Pharmaceuticals Inc said its experimental blood thinner was more effective than a commonly prescribed anticoagulant in patients undergoing total knee replacement surgery. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/YPfYVCFynCQ/story01.htm

Read More